A Compound from Black Pepper Reduces Inflammation and Pain by Boosting the Body's Own Cannabinoids
Guineensine, a compound found in black pepper, produced potent anti-inflammatory and pain-relieving effects in mice by blocking the reuptake of endocannabinoids, with effects partially dependent on CB1 receptors.
Quick Facts
What This Study Found
Guineensine, a dietary compound present in both black and long pepper, was previously shown to inhibit cellular endocannabinoid uptake, effectively boosting the body's own cannabinoid levels. Researchers tested whether this mechanism would translate to anti-inflammatory and pain-relieving effects in living animals.
The results were potent: guineensine inhibited inflammatory pain by 95.6% at 2.5 mg/kg, reduced edema (swelling) by 50.0% at 5 mg/kg, and produced acute pain relief of 66.1% at 5 mg/kg. It also suppressed inflammatory cytokine production during endotoxemia.
The pain relief and hypothermia caused by guineensine were blocked by the CB1 antagonist rimonabant, confirming involvement of the endocannabinoid system. However, guineensine also showed activity at dopamine transporters, serotonin 5HT2A receptors, and sigma receptors, revealing a broader pharmacological profile than previously appreciated.
Key Numbers
Inflammatory pain inhibition: 95.6% at 2.5 mg/kg. Edema inhibition: 50.0% at 5 mg/kg. Acute analgesia: 66.1% at 5 mg/kg. Effects on pain and hypothermia blocked by CB1 antagonist rimonabant. Additional targets: dopamine transporter (DAT), 5HT2A, sigma receptors.
How They Did This
Mouse models of acute and inflammatory pain and endotoxemia. Guineensine was injected intraperitoneally at various doses. CB1 receptor involvement was tested using the antagonist rimonabant. A screen of 45 CNS-related receptors, ion channels, and transporters was performed to identify additional targets.
Why This Research Matters
The idea that a common dietary compound from black pepper could produce significant anti-inflammatory and analgesic effects through the endocannabinoid system is intriguing. It supports the concept that endocannabinoid tone, not just direct receptor activation by THC, plays an important role in pain and inflammation regulation.
The Bigger Picture
This study connects dietary compounds to the endocannabinoid system in a pharmacologically meaningful way. The historical use of black pepper as a folk remedy for pain and inflammation may have a scientific basis through endocannabinoid modulation. The finding also relates to the "entourage effect" concept, where non-cannabinoid compounds may enhance endocannabinoid signaling.
What This Study Doesn't Tell Us
Animal study using intraperitoneal injection, not oral consumption. The doses needed for therapeutic effects may far exceed what dietary black pepper consumption provides. The polypharmacology (multiple receptor targets) makes it difficult to attribute effects solely to endocannabinoid mechanisms. No human studies exist for guineensine.
Questions This Raises
- ?Could dietary black pepper consumption meaningfully affect endocannabinoid levels in humans?
- ?Would oral guineensine retain its potency?
- ?Could guineensine or similar compounds be developed as endocannabinoid-boosting anti-inflammatory drugs?
Trust & Context
- Key Stat:
- 95.6% inhibition of inflammatory pain from a compound found in black pepper
- Evidence Grade:
- Preliminary evidence from animal models. No human studies on guineensine.
- Study Age:
- Published in 2017. Novel research on dietary endocannabinoid modulators.
- Original Title:
- An Endocannabinoid Uptake Inhibitor from Black Pepper Exerts Pronounced Anti-Inflammatory Effects in Mice.
- Published In:
- Journal of agricultural and food chemistry, 65(43), 9435-9442 (2017)
- Authors:
- Reynoso-Moreno, Inés, Najar-Guerrero, Israel, Escareño, Noé, Flores-Soto, Mario Eduardo, Gertsch, Jürg, Viveros-Paredes, Juan Manuel
- Database ID:
- RTHC-01500
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Can eating black pepper boost my endocannabinoid system?
Guineensine is present in black pepper and does inhibit endocannabinoid uptake in laboratory settings. However, the doses that produced effects in this mouse study were administered by injection and may far exceed what you would get from dietary pepper consumption. It is too early to draw dietary recommendations from this research.
Is this related to the idea of combining black pepper with cannabis?
There is a folk tradition suggesting black pepper can modulate cannabis effects. This study provides a potential mechanism (endocannabinoid uptake inhibition) but was not designed to test that specific claim. The compound beta-caryophyllene in black pepper is also known to interact with CB2 receptors.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
- cannabis-and-arthritis-research
Cite This Study
https://rethinkthc.com/research/RTHC-01500APA
Reynoso-Moreno, Inés; Najar-Guerrero, Israel; Escareño, Noé; Flores-Soto, Mario Eduardo; Gertsch, Jürg; Viveros-Paredes, Juan Manuel. (2017). An Endocannabinoid Uptake Inhibitor from Black Pepper Exerts Pronounced Anti-Inflammatory Effects in Mice.. Journal of agricultural and food chemistry, 65(43), 9435-9442. https://doi.org/10.1021/acs.jafc.7b02979
MLA
Reynoso-Moreno, Inés, et al. "An Endocannabinoid Uptake Inhibitor from Black Pepper Exerts Pronounced Anti-Inflammatory Effects in Mice.." Journal of agricultural and food chemistry, 2017. https://doi.org/10.1021/acs.jafc.7b02979
RethinkTHC
RethinkTHC Research Database. "An Endocannabinoid Uptake Inhibitor from Black Pepper Exerts..." RTHC-01500. Retrieved from https://rethinkthc.com/research/reynoso-moreno-2017-an-endocannabinoid-uptake-inhibitor
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.